Abstract

Metabolomics, the comprehensive analysis of small-molecule metabolites in biological samples, offers significant 
potential to improve health outcomes and support sustainable development in low- and middle-income countries 
(LMICs). However, its implementation raises complex ethical, legal, and social implications, particularly regarding 
informed consent, governance, data sharing, and community trust. LMICs face unique challenges, including 
variable regulatory frameworks, limited institutional capacity, and socio-cultural factors that influence 
participation and understanding of research. Broad and specific consent models, data stewardship practices, 
equitable benefit-sharing, and participatory community engagement emerge as critical mechanisms for ethical 
metabolomics research. Case studies from Ghana and Zimbabwe highlight the importance of context-specific 
governance and culturally appropriate engagement strategies. Addressing these challenges requires strengthening 
governance frameworks, enhancing interoperability of metabolomics data, and fostering durable trust through 
transparency, stakeholder engagement, and fair access to benefits. This paper emphasises the need for evidence
informed policy development and localised ethical standards to ensure that metabolomics research contributes 
meaningfully to health equity, scientific advancement, and sustainable development in LMICs.